Ignite Creation Date:
2025-12-24 @ 3:29 PM
Ignite Modification Date:
2026-03-04 @ 10:12 PM
Study NCT ID:
NCT04556292
Status:
UNKNOWN
Last Update Posted:
2020-09-21
First Post:
2020-09-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients
Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-15
First Submit QC Date:
None
Study First Post Date:
2020-09-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-18
Last Update Post Date:
2020-09-21
Last Update Post Date Type:
ACTUAL